Activation of the TLR5/MyD88/NME3/NFκB signaling pathway enhances host immunity, enhances the clearance of tumor xenografts, and potentially augments the effectiveness of immunotherapy, prolonging survival in breast cancer patients (91). The gene discussed is NFKB1; the disease is neoplasm.